Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambr Nutri Sci Regulatory News (CNSL)

Share Price Information for Cambr Nutri Sci (CNSL)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.70
Ask:
2.00
Spread: 0.30 (17.647%)
Market Cap: £4.40m
CNSL Live PriceLast checked at - London Stock Exchange

Intraday Cambr Nutri Sci Share Chart

Directorate Change

10 Jul 2025 07:00

RNS Number : 4485Q
Cambridge Nutritional Sciences PLC
10 July 2025
 

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

Directorate Change

 

CNSL (AIM:CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, is pleased to announce that it has appointed Ajay Patel to the Board as Chief Financial Officer ("CFO") and Executive Director with immediate effect.

Ajay has over 30 year's experience in finance, having graduated from University College London, trained at PWC, and spending 14 years at Tesco in a range of senior finance roles. He has significant CFO and Company secretary exposure to growing businesses in retail, e-commerce, logistics, wholesaling, education and charities. 

Carolyn Rand, Chair, said: "As a Board, I am delighted to welcome someone with Ajay's experience into our business to work alongside our CEO to help drive the business forward and deliver our strategy. This is evidence of our commitment to strengthening our Board with individuals who bring a wealth of experience and strategic insight into the organisation. I am sure, together with James we have a very strong Executive team who will play a key part in our future success".

James Cooper, Chief Executive Officer, said: "I am very pleased to welcome Ajay to our Board and look forward to working closely with him to achieve our strategic objectives. Ajay has significant experience and I am very excited at how this can help drive our growth agenda as well as develop our people and leadership in the organisation."

 

Contacts: 

Cambridge Nutritional Sciences Plc

www.cnsplc.com

James Cooper, Chief Executive Officer

investors@cnsplc.com

Cavendish Capital Markets Limited  

Tel: 020 7220 0500

Geoff Nash / Edward Whiley (Corporate Finance)

Nigel Birks / Harriet Ward (ECM)

 

About Cambridge Nutritional Sciences Plc

Cambridge Nutritional Sciences Plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

 

The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies: 

Ajay Patel, aged 60, does not currently hold any ordinary shares in the Company. Ajay also holds no options in the Company.

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

Current Directorships and Partnerships

Previous Directorships and Partnerships (held in the past five years)

A Tunnel Wood Limited

Entoria Winecellars Limited

TBP Realisations Limited

Tengo (Holdings) Limited

M & G Presents Limited

Tengo Limited

TBP Realisations Group Limited

Sonderwell Bidco Limited

Better Healthcare Services Limited

Enviva Care Limited

Invent Health Limited

Enviva Complex Care Limited

Libertatem Healthcare Group Limited

Sonderwell Midco Limited

Sonderwell Finco Limited

BECC: Bespoke Complex Care Support Limited

Arrow Support Limited

Diversity Care Solutions Limited

Libertatem Healthcare Holdings Ltd

Sonderwell Topco limited

Sekforde Drinks Limited

Great Western Wine Company Limited (The)

Coe of Ilford Limited

Gin Foundry Limited

Winecellars Limited

Entoria Winecellars Limited

Entoria Group Limited

Entoria Holdings Limited

 

TBP Realisations Limited (formerly The Book People Limited) appointed administrators on 16 December 2019. PWC were appointed originally to affect an accelerated M&A process with parallel contingency planning, but no buyer was secured. The final administrator's progress report reported that secured creditor Endless LLP had received £11.10 million while unsecured creditors received 3.69% totalling £541,000.00.

Tengo (Holdings) Limited, M & G Presents Limited, Tengo Limited and TBP Realisations Group Limited all entered Creditors Voluntary Liquidation on 13 March 2020. No realisations were made from the liquidations.

Squeaky Gate entered Creditor's Voluntary Liquidation on 14 April 2014. Non-preferential unsecured creditors claimed £319,373.1. No dividend was declared to these unsecured creditors.

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUQPMUPAPUB
12
Date   Source Headline
22nd Apr 20267:00 amRNSTrading & Business Update
31st Mar 20265:35 pmRNSHolding(s) in Company
31st Mar 20265:32 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSHalf-year Report
4th Nov 20257:00 amRNSNotice of Results & Investor Presentation
25th Sep 20254:30 pmRNSResult of AGM
28th Aug 20257:00 amRNSNotice of AGM & Annual Report
21st Aug 20257:00 amRNSGrant of Options
19th Aug 20257:00 amRNSFinal Results
31st Jul 20257:00 amRNSNotice of Results & Investor Presentation
10th Jul 20257:00 amRNSDirectorate Change
2nd Jul 20257:00 amRNSHolding(s) in Company
27th May 20257:00 amRNSTrading Update
23rd May 20257:00 amRNSResolution on HSE Matter
8th Apr 20257:00 amRNSGrant of Options
1st Apr 20257:00 amRNSAppointment of Chief Executive Officer
21st Mar 202511:33 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSOmega Diagnostics Summons Update
18th Mar 20252:48 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSDirector/PDMR Shareholding
30th Jan 20259:41 amRNSDirector/PDMR Shareholding
21st Jan 20254:03 pmRNSOmega Diagnostics court summons
16th Jan 20257:00 amRNSSettlement of DHSC Claim
7th Jan 20255:25 pmRNSHolding(s) in Company
7th Jan 20255:20 pmRNSHolding(s) in Company
4th Dec 20241:33 pmRNSHolding(s) in Company
4th Dec 20241:32 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSHalf-year Report
15th Nov 20249:24 amRNSNotice of Results and Investor Presentation
27th Sep 202411:20 amRNSResult of AGM
15th Aug 20243:44 pmRNSPosting of Annual Report and Notice of AGM
13th Aug 20247:00 amRNSDirectorate Change
5th Aug 202410:29 amRNSGrant of Options
25th Jul 20247:00 amRNSFinal Results
10th Jul 20247:00 amRNSNotice of Results
6th Jun 20244:26 pmRNSGrant of Options
24th May 20247:00 amRNSDirectorate Change
22nd Apr 20248:21 amRNSTrading Update and Directorate Change
3rd Apr 20247:00 amRNSQ2 2024 Industry Events Schedule
30th Jan 202412:50 pmRNSIssue of Equity and Total Voting Rights
29th Jan 20247:00 amRNSAppointment of Operations Director
22nd Jan 20247:00 amRNSScientific Educational Webinar and Industry Event
18th Dec 20233:51 pmRNSHolding(s) in Company
4th Dec 20237:00 amRNSScientific Educational Programme expanded
28th Nov 20233:56 pmRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
22nd Nov 202310:59 amRNSHolding(s) in Company
20th Nov 202311:09 amRNSHolding(s) in Company
17th Nov 202312:55 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.